comparemela.com

Inspirion Wealth Advisors News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Catalys Pacific LLC Makes New Investment in Phathom Pharmaceuticals, Inc (NASDAQ:PHAT)

Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]

PDS Biotechnology s (PDSB) Overweight Rating Reaffirmed at Cantor Fitzgerald

PDS Biotechnology s (PDSB) Overweight Rating Reaffirmed at Cantor Fitzgerald
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

iShares S&P Mid-Cap 400 Growth ETF (NYSEARCA:IJK) Shares Sold by Spire Wealth Management

iShares S&P Mid-Cap 400 Growth ETF (NYSEARCA:IJK) Shares Sold by Spire Wealth Management
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Axonics (NASDAQ:AXNX) Rating Reiterated by Needham & Company LLC

Axonics (NASDAQ:AXNX) Rating Reiterated by Needham & Company LLC
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

AdaptHealth Corp (NASDAQ:AHCO) Receives Average Recommendation of Hold from Analysts

Shares of AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report) have been given an average rating of “Hold” by the seven ratings firms that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and three have given a buy rating to the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.